Stay updated with breaking news from Iontech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) and BioNTech SE (BNTX) said Friday that they have completed a submission to the European Medicines Agency or EMA for a booster dose of an Omicron BA.4/BA.5-adapted
Moderna filed a patent infringement lawsuit against Pfizer-BioNTech.
Moderna and Pfizer’s two-shot vaccines both use mRNA technology to help patients fight the coronavirus.
Complaints to be filed in both United States and Germany alleging that Pfizer and BioNTech's COVID-19 vaccine Comirnaty® unlawfully infringes patents Moderna filed between 2010 and 2016Moderna not seeking
Moderna filed a patent infringement lawsuit against Pfizer-BioNTech.